This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Biogen Idec Inc, Elan Pharmaceuticals Inc.Important safety information - TYSABRI (Rm) (natalizumab). Internet Document: [2 pages], Feb 2008. Available from: URL: http://www.fda.gov
About this article
Cite this article
Tysabri label update: liver injury. React. Wkly. 1192, 2 (2008). https://doi.org/10.2165/00128415-200811920-00002
- Public Health
- Liver Injury
- Healthcare Professional
- Causative Agent